Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Hisataka Yasuda"'
Autor:
Yoshikazu Kuboi, Yukiko Kuroda, Masayoshi Ohkuro, Sotaro Motoi, Yoshiya Tomimori, Hisataka Yasuda, Nobuyuki Yasuda, Toshio Imai, Koichi Matsuo
Publikováno v:
JBMR Plus, Vol 6, Iss 10, Pp n/a-n/a (2022)
ABSTRACT The chemokine fractalkine (FKN) is produced by various cell types, including osteoblasts and endothelial cells in bone tissue, and signals through a sole receptor, CX3CR1, which is expressed on monocytes/macrophages, including osteoclast pre
Externí odkaz:
https://doaj.org/article/d904024bfa4d45d180a9e9f6584da8eb
Autor:
Naoto Tokuyama, Jun Hirose, Yasunori Omata, Tetsuro Yasui, Naohiro Izawa, Takumi Matsumoto, Hironari Masuda, Toshinobu Ohmiya, Hisataka Yasuda, Taku Saito, Yuho Kadono, Sakae Tanaka
Publikováno v:
Bone Reports, Vol 2, Iss C, Pp 1-7 (2015)
We examined the individual and combined effects of teriparatide and anti-RANKL (receptor activator of nuclear factor κB ligand) monoclonal antibody in ovariectomized mice. Three-month-old female C57BL/6 mice were ovariectomized (OVX) or sham operate
Externí odkaz:
https://doaj.org/article/00e648e8614a4c38852c5f4c862a6bfd
Autor:
Yuki Ozaki, Masanori Koide, Yuriko Furuya, Tadashi Ninomiya, Hisataka Yasuda, Midori Nakamura, Yasuhiro Kobayashi, Naoyuki Takahashi, Nobuo Yoshinari, Nobuyuki Udagawa
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184904 (2017)
Osteoblasts express two key molecules for osteoclast differentiation, receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG), a soluble decoy receptor for RANKL. RANKL induces osteoclastogenesis, while OPG inhibits it by blocking the b
Externí odkaz:
https://doaj.org/article/2487bcb9da944fa09fe246d8594a0abf
Autor:
Yukiko Kuroda, Kenta Maruyama, Hideki Fujii, Isamu Sugawara, Shigeru B H Ko, Hisataka Yasuda, Hidenori Matsui, Koichi Matsuo
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146544 (2016)
Osteoprotegerin (OPG), a decoy receptor for receptor activator of NF-κB ligand (RANKL), antagonizes RANKL's osteoclastogenic function in bone. We previously demonstrated that systemic administration of lipopolysaccharide (LPS) to mice elevates OPG l
Externí odkaz:
https://doaj.org/article/c7fe118a43da431faca26153b807a1b0
Autor:
Keigo Nakamura, Masanori Koide, Yasuhiro Kobayashi, Teruhito Yamashita, Mai Matsushita, Hisataka Yasuda, Yuichi Ishihara, Nobuo Yoshinari, Nobuyuki Udagawa
Publikováno v:
Journal of Periodontal Research.
Autor:
Yoshikazu Kuboi, Yukiko Kuroda, Masayoshi Ohkuro, Sotaro Motoi, Yoshiya Tomimori, Hisataka Yasuda, Nobuyuki Yasuda, Toshio Imai, Koichi Matsuo
Publikováno v:
JBMR Plus. 6
The chemokine fractalkine (FKN) is produced by various cell types, including osteoblasts and endothelial cells in bone tissue, and signals through a sole receptor, CX3CR1, which is expressed on monocytes/macrophages, including osteoclast precursors (
Autor:
null Yoshikazu Kuboi, null Yukiko Kuroda, null Masayoshi Ohkuro, null Sotaro Motoi, null Yoshiya Tomimori, null Hisataka Yasuda, null Nobuyuki Yasuda, null Toshio Imai, null Koichi Matsuo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abacf3e80f751ef2e03a6b56d59f7726
https://doi.org/10.1002/jbm4.10680/v2/response1
https://doi.org/10.1002/jbm4.10680/v2/response1
Publikováno v:
Journal of Oral Biosciences. 63:45-51
Objectives Osteoclasts are induced by macrophage colony-stimulating factor-1 (CSF-1) and receptor activator of nuclear factor-κB (RANK) ligand (RANKL). Monocyte/macrophage lineages are thought to be osteoclast precursors; however, such cells have no
Autor:
Masanori Koide, Teruhito Yamashita, Keigo Nakamura, Hisataka Yasuda, Nobuyuki Udagawa, Yasuhiro Kobayashi
Publikováno v:
Bone. 160
Bone formation by osteoblasts is achieved through remodeling-based bone formation (RBBF) and modeling-based bone formation (MBBF). The former is when bone formation occurs after osteoclastic bone resorption to maintain bone mass and calcium homeostas
Publikováno v:
Glycoconjugate Journal. 38:293-301
Methylglyoxal (MGO) produced during glycolysis is known to react with arginine residues on proteins to generate advanced glycation end products, such as Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine (MG-H1). Since the production of MGO is incre